AccuTheranostics Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 3
Employees
  • Latest Deal Type
  • Accelerator/​Inc
  • Latest Deal Amount
  • $62.5K
Latest Deal Amount
  • Investors
  • 4

AccuTheranostics General Information

Description

Provider of biomedical and clinical services intended to provide essential information for the treatment of an individual patient's cancer.. The company's biomedical and clinical services include a specialized chemo sensitive and chemo resistance assay using a patient's own tumor cells in a laboratory to identify which drugs have the most and the least, potential for treating patient's unique cancer, enabling physicians to avoid the use of specific chemotherapy agents to which the patient's tumor is resistant and select those that will be most effective.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Primary Office
  • 875 Ellicott Street
  • Suite 5080
  • Buffalo, NY 14203
  • United States
+1 (716) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AccuTheranostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 08-Sep-2017 $62.5K 000.00 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2016 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Accelerator/Incubator 24-Oct-2012 Completed Generating Revenue
To view AccuTheranostics’s complete valuation and funding history, request access »

AccuTheranostics Executive Team (3)

Name Title Board Seat Contact Info
Steven Cerne Co-Founder & Chief Executive Officer
Sherry Bradford Ph.D Co-Founder, CSO & President
Arvind Thakur Ph.D Co-Founder & Vice President, Scientific Affairs
To view AccuTheranostics’s complete executive team members history, request access »

AccuTheranostics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AccuTheranostics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Launch NY Venture Capital Minority 000 0000 000000 0
43North Accelerator/Incubator Minority 000 0000 000000 0
UB Incubator Accelerator/Incubator Minority 000 0000 000000 0
The InVentures Group Accelerator/Incubator Minority 000 0000 000000 0
To view AccuTheranostics’s complete investors history, request access »